blank Quick help
blank Maintenance news

Scheduled maintenance

Regular maintenance outages:
between 05.00 and 05.15 hrs CET (Monday to Sunday).

Other outages
Availability

2022.02.11

More...
blank News flashes

News Flashes

New version of the European Patent Register – SPC proceedings information in the Unitary Patent Register.

2024-07-24

More...
blank Related links

Extract from the Register of European Patents

EP About this file: EP1056839

EP1056839 - PHARMACEUTICAL FORMULATION CONTAINING A MICROBIAL ENZYME WHICH DIGESTS HYALURONIC ACID [Right-click to bookmark this link]
StatusThe application is deemed to be withdrawn
Status updated on  07.05.2004
Database last updated on 02.11.2024
Most recent event   Tooltip07.05.2004Application deemed to be withdrawnpublished on 23.06.2004  [2004/26]
Applicant(s)For all designated states
Id Pharma GmbH
Markt 2
07743 Jena / DE
For all designated states
Friedrich-Schiller-Universität Jena
Fürstengraben 1
07743 Jena / DE
For all designated states
Presselt, Norbert
Eichicht 2
07768 Kahla / DE
[2000/49]
Inventor(s)01 / PRESSELT, Norbert
Eichicht 2
D-07768 Kahla / DE
02 / MÜLLER, Peter-Jürgen
Kastanienweg 4
D-07745 Jena / DE
03 / OZEGOWSKI, Jörg-Hermann
Novalisstrasse 17
D-07747 Jena / DE
04 / HÄRTL, Albert
Oskar-Zachau-Strasse 10
D-07749 Jena / DE
05 / PESCHEL, Gundela
Closewitzer Strasse 21g
D-07743 Jena / DE
[2000/49]
Representative(s)(deleted)
[2002/03]
Former [2000/49]Störle, Christian, Dr., et al
Geyer, Fehners & Partner, Perhamerstrasse 31
80687 München / DE
Application number, filing date99964464.422.12.1999
[2000/49]
WO1999DE04108
Priority number, dateDE199816054123.12.1998         Original published format: DE 19860541
DE199816054223.12.1998         Original published format: DE 19860542
[2000/49]
Filing languageDE
Procedural languageDE
PublicationType: A2 Application without search report
No.:WO0039290
Date:06.07.2000
[2000/27]
Type: A1 Application with search report 
No.:EP1056839
Date:06.12.2000
Language:DE
The application published by WIPO in one of the EPO official languages on 06.07.2000 takes the place of the publication of the European patent application.
[2000/49]
Search report(s)International search report - published on:EP08.03.2001
ClassificationIPC:C12N9/88, A61K38/51, A61P7/02, A61P9/06, A61P9/10
[2000/49]
CPC:
A61K38/51 (EP); C12N9/88 (EP,KR); A61P7/02 (EP);
A61P9/06 (EP); A61P9/10 (EP); C12Y402/02001 (EP)
Designated contracting statesAT,   BE,   CH,   CY,   DE,   DK,   ES,   FI,   FR,   GB,   GR,   IE,   IT,   LI,   LU,   MC,   NL,   PT,   SE [2000/49]
Extension statesALNot yet paid
LTNot yet paid
LVNot yet paid
MKNot yet paid
RONot yet paid
SINot yet paid
TitleGerman:PHARMAZEUTISCHE FORMULIERUNG ENTHALTEND EIN HYALURONSÄURE-SPALTENDES ENZYM MIKROBIELLER HERKUNFT[2000/49]
English:PHARMACEUTICAL FORMULATION CONTAINING A MICROBIAL ENZYME WHICH DIGESTS HYALURONIC ACID[2000/49]
French:FORMULATION PHARMACEUTIQUE CONTENANT UN ENZYME DECOMPOSANT L'ACIDE HYALURONIQUE ET D'ORIGINE MICROBIENNE[2000/49]
Entry into regional phase21.08.2000National basic fee paid 
21.08.2000Designation fee(s) paid 
21.08.2000Examination fee paid 
Examination procedure21.08.2000Examination requested  [2000/49]
02.07.2002Application deemed to be withdrawn, date of legal effect  [2004/26]
08.08.2003Despatch of communication that the application is deemed to be withdrawn, reason: renewal fee not paid in time  [2004/26]
Fees paidPenalty fee
Additional fee for renewal fee
31.12.200103   M06   Not yet paid
31.12.200204   M06   Not yet paid
31.12.200305   M06   Not yet paid
Opt-out from the exclusive  Tooltip
competence of the Unified
Patent Court
See the Register of the Unified Patent Court for opt-out data
Responsibility for the accuracy, completeness or quality of the data displayed under the link provided lies entirely with the Unified Patent Court.
Cited inInternational search[A]GB1120298  (BIOREX LABORATORIES LTD) [A] 1-12 * the whole document *;
 [YD]US3708575  (GOTTFRIED S) [YD] 1-12 * the whole document *;
 [X]US3728223  (KANEKO Y, et al) [X] 1,2 * the whole document *;
 [E]WO0038732  (ESPARMA GMBH [DE], et al) [E] 1-4,9* the whole document *;
 [YD]  - OZEGOWSKI JOERG-HERMANN ET AL, "Purification and characterization of hyaluronidase from Streptococcus agalactiae.", ZENTRALBLATT FUER BAKTERIOLOGIE, (1994), vol. 280, no. 4, ISSN 0934-8840, pages 497 - 506, XP000929980 [YD] 1-12 * the whole document *
 [DA]  - WOLFF L, "Behandlungsergebnisse mit intravenösen Magnesium comp./Hylase-Mischinjektionen bei Arteriopathien vom Beckentyp im Stadium II", ZEITSCHRIFT FÜR ÄRZTLICHE FORTBILDUNG, (1972), vol. 66, no. 9, pages 446 - 447, XP000929961 [DA] 1-12 * the whole document *
 [A]  - LEABACK D H ET AL, "THE MODE OF ACTION AND POSSIBLE BIOLOGICAL ROLES OF BACTERIAL HYALURONATE LYASE", BIOCHEMICAL SOCIETY TRANSACTIONS, (1973), vol. 1, no. 4, ISSN 0300-5127, pages 949 - 951, XP000929981 [A] 1-12 * the whole document *
The EPO accepts no responsibility for the accuracy of data originating from other authorities; in particular, it does not guarantee that it is complete, up to date or fit for specific purposes.